Download PDF
TumorDiagnostik & Therapie 2021; 42(04): 262-276
DOI: 10.1055/a-1394-1937
Schwerpunkt Tumoren des Auges

Tumoren und Pseudotumoren der Netzhaut und des Ziliarepithels

Eva Biewald
,
Sabrina Schlüter
,
Tobias Kiefer
,
Sami Dalbah
,
Norbert Bornfeld
,
Nikolaos E. Bechrakis
› Further Information
Also available at
    Permissions and Reprints

Die Varietät retinaler Tumoren reicht von harmlosen Läsionen über benigne, lokal destruierende Tumoren bis hin zu lebensbedrohlichen Erkrankungen. Nicht immer lassen sie sich einfach voneinander unterscheiden. Die Diagnose sollte nach Möglichkeit klinisch gestellt werden wegen der Gefahr einer Tumorzellverschleppung durch invasive Diagnostik. Jedoch rückt die genetische Charakterisierung der Läsion immer mehr in den Vordergrund. Je nach Entität ist eine Therapie in einem spezialisierten Zentrum notwendig.

Publication History

Article published online:
30 April 2021

© 2020. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 

  • Literatur

  • 1 Dimaras H, Corson TW, Cobrinik D. et al Retinoblastoma. Nat Rev Dis Primers 2015; 1: 15021
    CrossrefPubMedSearch in Google Scholar
  • 2 Linn Murphree A. Intraocular retinoblastoma: the case for a new group classification. Ophthalmol Clin North Am 2005; 18: 41-53, viii
    CrossrefPubMedSearch in Google Scholar
  • 3 Lohmann D. Retinoblastoma. Adv Exp Med Biol 2010; 685: 220-227
    CrossrefPubMedSearch in Google Scholar
  • 4 Biewald E, Holdt M, Bornfeld N. Neue Therapiestrategien beim Retinoblastom: Nichtsystemische Chemotherapie. Ophthalmologe 2014; 111: 379-382
    CrossrefPubMedSearch in Google Scholar
  • 5 Temming P, Arendt M, Viehmann A. et al Incidence of second cancers after radiotherapy and systemic chemotherapy in heritable retinoblastoma survivors: A report from the German reference center. Pediatr Blood Cancer 2017; 64: 71-80
    CrossrefPubMedSearch in Google Scholar
  • 6 Bechrakis NE, Bornfeld N, Schueler A. et al Clinicopathologic features of retinoblastoma after primary chemoreduction. Arch Ophthalmol 1998; 116: 887-893
    CrossrefPubMedSearch in Google Scholar
  • 7 Shields CL, Mashayekhi A, Au AK. et al The International Classification of Retinoblastoma predicts chemoreduction success. Ophthalmology 2006; 113: 2276-2280
    CrossrefPubMedSearch in Google Scholar
  • 8 Pekacka A. The Role of Intraarterial Chemotherapy in the Management of Retinoblastoma. J Ophthalmol 2020; 2020: 3638410
    CrossrefPubMedSearch in Google Scholar
  • 9 Manjandavida FP, Stathopoulos C, Zhang J. et al Intra-arterial chemotherapy in retinoblastoma – A paradigm change. Indian J Ophthalmol 2019; 67: 740-754
    CrossrefPubMedSearch in Google Scholar
  • 10 Biewald EM, Bornfeld N, Metz KA. et al Histopathology of retinoblastoma eyes enucleated after intra-arterial chemotherapy. Br J Ophthalmol 2019;
    CrossrefPubMedSearch in Google Scholar
  • 11 Suzuki S, Aihara Y, Fujiwara M. et al Intravitreal injection of melphalan for intraocular retinoblastoma. Jpn J Ophthalmol 2015; 59: 164-172
    CrossrefPubMedSearch in Google Scholar
  • 12 Munier FL, Gaillard MC, Balmer A. et al Intravitreal chemotherapy for vitreous seeding in retinoblastoma: Recent advances and perspectives. Saudi J Ophthalmol 2013; 27: 147-150
    CrossrefPubMedSearch in Google Scholar
  • 13 Francis JH, Brodie SE, Marr B. et al Efficacy and Toxicity of Intravitreous Chemotherapy for Retinoblastoma: Four-Year Experience. Ophthalmology 2017; 124: 488-495
    CrossrefPubMedSearch in Google Scholar
  • 14 Sen M, Shields CL, Honavar SG. et al Coats disease: An overview of classification, management and outcomes. Indian J Ophthalmol 2019; 67: 763-771
    CrossrefPubMedSearch in Google Scholar
  • 15 Robitaille JM, Zheng B, Wallace K. et al The role of Frizzled-4 mutations in familial exudative vitreoretinopathy and Coats disease. Br J Ophthalmol 2011; 95: 574-579
    CrossrefPubMedSearch in Google Scholar
  • 16 Statland JM, Sacconi S, Farmakidis C. et al Coats syndrome in facioscapulohumeral dystrophy type 1: frequency and D4Z4 contraction size. Neurology 2013; 80: 1247-1250
    CrossrefPubMedSearch in Google Scholar
  • 17 Daruich AL, Moulin AP, Tran HV. et al Subfoveal nodule in coatsʼ disease: Toward an updated classification predicting visual prognosis. Retina 2017; 37: 1591-1598
    CrossrefPubMedSearch in Google Scholar
  • 18 Kase S, Rao NA, Yoshikawa H. et al Expression of vascular endothelial growth factor in eyes with Coatsʼ disease. Invest Ophthalmol Vis Sci 2013; 54: 57-62
    CrossrefPubMedSearch in Google Scholar
  • 19 Kusaka S. Surgical management of coats disease. Asia Pac J Ophthalmol (Phila) 2018; 7: 156-159
    CrossrefPubMedSearch in Google Scholar
  • 20 Kaliki S, Taneja S, Palkonda VAR. Inadvertent intraocular surgery in children with unsuspected retinoblastoma: a study of 14 cases. Retina 2019; 39: 1794-1801
    CrossrefPubMedSearch in Google Scholar
  • 21 Soliman SE, Wan MJ, Heon E. et al Retinoblastoma versus advanced Coatsʼ disease: Is enucleation the answer?. Ophthalmic Genet 2017; 38: 291-293
    CrossrefPubMedSearch in Google Scholar
  • 22 Hiscott P, Mudhar H. Is vasoproliferative tumour (reactive retinal glioangiosis) part of the spectrum of proliferative vitreoretinopathy?. Eye 2009; 23: 1851-1858
    CrossrefPubMedSearch in Google Scholar
  • 23 Anastassiou G, Bornfeld N, Schueler AO. et al Ruthenium-106 plaque brachytherapy for symptomatic vasoproliferative tumours of the retina. Br J Ophthalmol 2006; 90: 447-450
    CrossrefPubMedSearch in Google Scholar
  • 24 Hussain RN, Jmor F, Damato B. et al Verteporfin photodynamic therapy for the treatment of retinal vasoproliferative tumors. Ophthalmology 2015; 122: 2361-2363
    CrossrefPubMedSearch in Google Scholar
  • 25 Saito W, Kase S, Fujiya A. et al Expression of vascular endothelial growth factor and intravitreal anti-VEGF therapy with bevacizumab in vasoproliferative retinal tumors. Retina 2013; 33: 1959-1967
    CrossrefPubMedSearch in Google Scholar
  • 26 Smith J, Steel D. The surgical management of vasoproliferative tumours. Ophthalmologica 2011; 226 (Suppl. 01) 42-45
    CrossrefPubMedSearch in Google Scholar
  • 27 Binderup MLM, Stendell AS, Galanakis M. et al Retinal hemangioblastoma: prevalence, incidence and frequency of underlying von Hippel-Lindau disease. Br J Ophthalmol 2018; 102: 942-947
    CrossrefPubMedSearch in Google Scholar
  • 28 Latif F, Tory K, Gnarra J. et al Identification ofnthe von Hippel-Lindau disease tumor suppressor gene. Science 1993; 260: 1317-1320
    CrossrefPubMedSearch in Google Scholar
  • 29 Richards FM, Payne SJ, Zbar B. et al Molecular analysis of de novo germline mutations in the von Hippel-Lindau disease gene. Hum Mol Genet 1995; 4: 2139-2143
    CrossrefPubMedSearch in Google Scholar
  • 30 Schmid S, Gillessen S, Binet I. et al Management of von Hippel-Lindau disease: an interdisciplinary review. Oncol Res Treat 2014; 37: 761-771
    CrossrefPubMedSearch in Google Scholar
  • 31 Singh AD, Nouri M, Shields CL. et al Treatment of retinal capillary hemangioma. Ophthalmology 2002; 109: 1799-1806
    CrossrefPubMedSearch in Google Scholar
  • 32 Gaudric A, Krivosic V, Duguid G. et al Vitreoretinal surgery for severe retinal capillary hemangiomas in von hippel-lindau disease. Ophthalmology 2011; 118: 142-149
    CrossrefPubMedSearch in Google Scholar
  • 33 Bornfeld N, Kreusel KM. Kapilläre Hämangiome der Netzhaut beim Von-Hippel-Lindau-Syndrom. Neue Therapieansätze. Ophthalmologe 2007; 104: 114-118
    CrossrefPubMedSearch in Google Scholar
  • 34 Kreusel KM, Bornfeld N, Lommatzsch A. et al Ruthenium-106 brachytherapy for peripheral retinal capillary hemangioma. Ophthalmology 1998; 105: 1386-1392
    CrossrefPubMedSearch in Google Scholar
  • 35 Garcia-Arumi J, Sararols LH, Cavero L. et al Therapeutic options for capillary papillary hemangiomas. Ophthalmology 2000; 107: 48-54
    CrossrefPubMedSearch in Google Scholar
  • 36 Hussain RN, Jmor F, Damato B. et al Verteporfin photodynamic therapy for the treatment of sporadic retinal capillary haemangioblastoma. Photodiagnosis Photodyn Ther 2015; 12: 555-560
    CrossrefPubMedSearch in Google Scholar
  • 37 Magee MA, Kroll AJ, Lou PL. et al Retinal capillary hemangiomas and von Hippel-Lindau disease. Semin Ophthalmol 2006; 21: 143-150
    CrossrefPubMedSearch in Google Scholar
  • 38 Heimann H, Damato B. Congenital vascular malformations of the retina and choroid. Eye 2010; 24: 459-467
    CrossrefPubMedSearch in Google Scholar
  • 39 Hewick S, Lois N, Olson JA. Circumferential peripheral retinal cavernous hemangioma. Arch Ophthalmol 2004; 122: 1557-1560
    CrossrefPubMedSearch in Google Scholar
  • 40 Holdt M, Jurklies C, Schueler A. et al Intraokulare Medulloepitheliome – klinische Serie mit 10 Fällen. Klin Monatsbl Augenheilkd 2009; 226: 1017-1022
    Thieme ConnectPubMedSearch in Google Scholar
  • 41 Zimmerman LE. Verhoeffʼs “terato-neuroma”. A critical reappraisal in light of new observations and current concepts of embryonic tumors. The Fourth Frederick H. Verhoeff Lecture. Am J Ophthalmol 1971; 72: 1039-1057
    CrossrefPubMedSearch in Google Scholar
  • 42 Tadepalli SH, Shields CL, Shields JA. et al Intraocular medulloepithelioma – A review of clinical features, DICER 1 mutation, and management. Indian J Ophthalmol 2019; 67: 755-762
    CrossrefPubMedSearch in Google Scholar
  • 43 Shields JA, Shields CL. Glial tumors of the retina. The 2009 King Khaled Memorial Lecture. Saudi J Ophthalmol 2009; 23: 197-201
    CrossrefPubMedSearch in Google Scholar
  • 44 Rowley SA, OʼCallaghan FJ, Osborne JP. Ophthalmic manifestations of tuberous sclerosis: a population based study. Br J Ophthalmol 2001; 85: 420-423
    CrossrefPubMedSearch in Google Scholar
  • 45 Toteberg-Harms M, Sturm V, Sel S. et al Retinal astrocytomas: long-term follow-up. Klin Monatsbl Augenheilkd 2011; 228: 337-339
    Thieme ConnectPubMedSearch in Google Scholar
  • 46 Good WV, Erodsky MC, Edwards MS. et al Bilateral retinal hamartomas in neurofibromatosis type 2. Br J Ophthalmol 1991; 75: 190
    CrossrefPubMedSearch in Google Scholar
  • 47 Cohen VM, Shields CL, Furuta M. et al Vitreous seeding from retinal astrocytoma in three cases. Retina 2008; 28: 884-888
    CrossrefPubMedSearch in Google Scholar
  • 48 Shields JA, Eagle jr RC, Shields CL. et al Aggressive retinal astrocytomas in 4 patients with tuberous sclerosis complex. Arch Ophthalmol 2005; 123: 856-863
    CrossrefPubMedSearch in Google Scholar
  • 49 Bornfeld N, Messmer EP, Theodossiadis G. et al Giant cell astrocytoma of the retina. Clinicopathologic report of a case not associated with Bournevilleʼs disease. Retina 1987; 7: 183-189
    CrossrefPubMedSearch in Google Scholar
  • 50 Singh AD, Soto H, Bellerive C. et al Reactive retinal astrocytic tumor (focal nodular gliosis): report of the clinical spectrum of 3 cases. Ocul Oncol Pathol 2017; 3: 235-239
    CrossrefPubMedSearch in Google Scholar
  • 51 Shields JA, Bianciotto CG, Kivela T. et al Presumed solitary circumscribed retinal astrocytic proliferation: the 2010 Jonathan W. Wirtschafter Lecture. Arch Ophthalmol 2011; 129: 1189-1194
    CrossrefPubMedSearch in Google Scholar
  • 52 Shields CL, Materin MA, Marr BP. et al Resolution of exudative retinal detachment from retinal astrocytoma following photodynamic therapy. Arch Ophthalmol 2008; 126: 273-274
    CrossrefPubMedSearch in Google Scholar
  • 53 Ramasubramanian A, Shields CL, Kytasty C. et al Resection of intraocular tumors (partial lamellar sclerouvectomy) in the pediatric age group. Ophthalmology 2012; 119: 2507-2513
    CrossrefPubMedSearch in Google Scholar
  • 54 Marciano S, Mutolo MG, Siracusano M. et al Everolimus for retinal astrocytic hamartomas in tuberous sclerosis complex. Ophthalmol Retina 2018; 2: 257-260
    Search in Google Scholar
  • 55 Gass JD. An unusual hamartoma of the pigment epithelium and retina simulating choroidal melanoma and retinoblastoma. Trans Am Ophthalmol Soc 1973; 71: 171-183 ; discussions 184–185
    PubMedSearch in Google Scholar
  • 56 Dedania VS, Ozgonul C, Zacks DN. et al Novel classification system for combined hamartoma of the retina and retinal pigment epithelium. Retina 2018; 38: 12-19
    CrossrefPubMedSearch in Google Scholar
  • 57 Grant EA, Trzupek KM, Reiss J. et al Combined retinal hamartomas leading to the diagnosis of neurofibromatosis type 2. Ophthalmic Genet 2008; 29: 133-138
    CrossrefPubMedSearch in Google Scholar
  • 58 Cohn AD, Quiram PA, Drenser KA. et al Surgical outcomes of epiretinal membranes associated with combined hamartoma of the retina and retinal pigment epithelium. Retina 2009; 29: 825-830
    CrossrefPubMedSearch in Google Scholar
  • 59 Regillo CD, Eagle Jr RC, Shields JA. et al Histopathologic findings in congenital grouped pigmentation of the retina. Ophthalmology 1993; 100: 400-405
    CrossrefPubMedSearch in Google Scholar
  • 60 Shields CL, Materin MA, Walker C. et al Photoreceptor loss overlying congenital hypertrophy of the retinal pigment epithelium by optical coherence tomography. Ophthalmology 2006; 113: 661-665
    CrossrefPubMedSearch in Google Scholar
  • 61 Rehan S, Aye K. In patients with a positive family history of familial adenomatous polyposis can the condition be diagnosed from the presence of congenital hypertrophy of the retinal pigment epithelium detected via an eye examination: A systematic review. Clin Exp Ophthalmol 2020; 48: 98-116
    CrossrefPubMedSearch in Google Scholar
  • 62 Trichopoulos N, Augsburger JJ, Schneider S. Adenocarcinoma arising fromcongenital hypertrophy of the retinal pigment epithelium. Graefes Arch Clin Exp Ophthalmol 2006; 244: 125-128
    CrossrefPubMedSearch in Google Scholar